Chairman’s Introduction and Overview
Program Chairman: Ken Jamerson, MD, FACC

Update on Hypertension Management: Recent Advances – Focus on Combination Therapy, Guideline Modifications and Comprehensive Cardiovascular Protection
Henry R. Black, MD

The Current Role of Vasodilatory Beta-1 Blockers for Hypertension Management – Novel Mechanisms of Action, Hemodynamic Effects, Cardiometabolic Profiles and Clinical Efficacy Across the Cardiovascular Risk Spectrum
L. Michael Prisant, MD, FACP, FACC, FAHA

Evidence-Based Use of Beta Blockers in Special Patient Populations – Safety and Efficacy of Cardioselective Beta-1 Blockade in African Americans, Diabetes, Heart Failure, the Elderly and Women with Hypertension
Ken Jamerson, MD, FACC

Question and Answer Session - Challenge the Experts
Faculty Panel